MFI Stock Review: Cephalon (CEPH)

Read the full article at: http://www.magicdiligence.com/articles/cephalon-CEPH-review-2009-11-05

(via www.magicdiligence.com)

Cephalon has three drugs with good growth potential. If sales develop according to the company's plan, the current price will prove to be a bargain.

Submitted by MagicDiligence on Thu, 2009-11-05 07:07.

Top Tickers

Taipan_Trader: Discussing in upcoming documentary RT @InvestInAfrica: South African inflation falls to 5.9%; lowest rate in 2 years http://bit.ly/6bAz0B

anniversary gifts for mom and dad - buy one share of stock